Human arsenic poisoning issues in central-east Indian locations: Biomarkers and biochemical monitoring

International Journal of Environmental Research and Public Health

Volumn 4, Issue 1, 2007, Pages 15-22

  Pandey, Piyush Kant ^a   Yadav, Sushma ^a   Pandey, Madhurima ^a  

^a BHILAI INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Arsenic; Biochemical arsenic monitoring; Biomonitoring; Central east india

Indexed keywords

ARSENIC; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; DRINKING WATER; GROUND WATER;

ADULT; AGE; ARSENIC POISONING; ARTICLE; BLOOD ANALYSIS; CORRELATION ANALYSIS; FEMALE; HAIR ANALYSIS; HUMAN; INDIA; MALE; NAIL; OUTCOME ASSESSMENT; RENAL SYSTEM PARAMETERS; SPECTROPHOTOMETRY; URINALYSIS;

EID: 34250373380     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph2007010003     Document Type: Article

References (25)

1. Tseng, W. P.: Effect and dose response relationship of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977, 19, 109-119.
2. US EPA (U. S. Environmental Protection Agency) IRIS (Integrated risk Information System) on line database maintained in Toxicology Data Network (TOXNET) by the national library of medicine, Bethesda, Maryland, 1997.
3. IARC (International agency for research on cancer) International agency for research on cancer, toxicological abbreviations, arsenic and arsenic compounds, IARC summary & Evaluation. 1987; Vol. 23. p. 100 (suppl. 7).
4. Pandey, P. K.; Khare, R. N.; Sharma, S.; Sar, S. K.; Pandey, M.; Binayke, P.: Arsenicosis and deteriorating groundwater quality: Unfolding crisis in central east India region. Curr Sci. 1999, 77, 686-693.
5. Pandey, P. K.; Yadav, S.; Nair, S.; Bhui, A.: Arsenic contamination of the environment: A new perspective from Central East India. Environ Int. 2002, 28, 235-345.
6. Pandey, P. K.; Nair, S.; Bhui, A.; Pandey, M.: Sediment contamination by arsenic in parts of central east India and analytical studies on its mobilization. Curr Sci. 2004, 86, 101-105.
7. WHO (World Health Organization). Fact Sheet no. 210. Arsenic in drinking water. Bulletin of the World health Organization, 2001; 78(9), 1096.
8. Valentine, J. L.; Kang, H. K.; Spivey, G.: Arsenic levels in human blood, urine and hair in response to exposure via drinking water. Environ Res. 1979, 20, 24-32.
9. Lerman, B. B.; Ali, N.; Green, D.: Megaloblastic, dioserytropoietic anaemia following arsenic ingestion. Ann Clin Lab Scvi. 1980, 10, 515-517.
10. Eichner, E. R.: Erytroid karyorrhexis in the peripheral blood smear in severe arsenic poisoning: A comparison with lead poisoning. A J Clin Pathol. 1984, 81, 533-537.
11. Rezuke, W. N.; Anderson, C.; Pastuszak, W. T.; Conway, S. R.; Firshiein, S. I.: Arsenic intoxication presenting as a myelodysplastic syndrome: A case report. Am J Hematol. 1991, 36, 291-293.
12. Haringson, J. M.; Middaaugh, J. P.; Morse, D. L.; Houseworth, J.: A survey of a population exposed to high concentration of arsenic in well water in Fairbanks. Alaska. Am J Epidemiol. 1978, 108, 377-385.
13. Morse, D. L.; Harrington, J. M.; Houseworth, J.; Landrigan, P. J.; Kelter, A.: Arsenic exposure in multiple environmental media in children near a smelter. Clin Toxicol. 1979, 14(4), 389-399.
14. Michigan Department of Public Health. Arsenic in drinking water - A study of exposure and a clinical survey. Division of Environmental Epidemiology, Bureau of Disease Control and Laboratory services. Environmental Health Statistics Unit, Technical Services Section, Office of Vital and Health Statistics, Department of Public Health, Lansing, Mich. 1982.
15. Southwick, J. W.; Western, A. E.; Beck, M. M.; Whitley, T.; Issac, R.; Pentajan. J.; Hansen, C.: An epedemiological study of arsenic in drinking water in Millard country, Utah, in Arsenic: Industrial, Biomedical, Environmental Perspectives, Lederer, W. H.; and Fensterheim, R. J., Eds.; New York: Van Nostrand Reinhold, 1983; 210-225.
16. Chen, C. J.; Chaung, Y. C.; You, S. L.; Lin, T. M.; Wu, H. Y.: A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer. 1986, 53, 399-405.
17. Chen, C. J.; Chiou, H.Y.; Huang, W. I.; Chen, S. Y.; Hsueh, Y. M.; Tseng, C. H.; Lin, L. J.; Shyu, M. P.; Lai, M. S.: Systemic non carcinogenic effects and developmental toxicity of inorganic arsenic. Abernathy, C.O.; Caideron, R. L.; Chapell, W. R., Eds.; Arsenic Exposure and Health Effects, 1997, 11, 124-134.
18. Chen, C. J.; Chuang, Y. C.; Lin, T. M.; Wu, H. Y.: Malignant neoplasma among residents of a blackfoot disease-endemic area in Taiwan: High arsenic artesian well water and cancer. Cancer Res. 1985, 45, 5895-5899.
19. Chen , C. J.; Hsueh, Y. M.; Lai, M. S.; Shyu, M. P.; Chen, S. Y.; Wu, M. M.; Kuo, T. L.; Tai, T. Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 1995, 25, 53-60.
20. Chen, C. J.; Wu, M. M.; Lee, S. S.; Wang, J. D.; Cheng, S. H.; Wu, H. Y.: Antherogenicity and carcinogenicity of high arsenic artesian well water. Multiple risk factor and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988, 8, 452-460.
21. Foa, V.; Colombi, A.; Maroni, M.: The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci. Total Environ. 1984, 34, 241-259.
22. Norin, H.; Vahter, M.: A rapid method for the selective analysis of total urinary metabolites of inorganic arsenic. Scand J Work Environ. Health. 1981, 7, 38-44.
23. Pinto, S. S.; Varner, M. O.; Nelson, K. W.: Arsenic trioxide absorption and excretion in industry. J. Occup. Med. 1976, 18(10), 677-680.
24. Curatola, C. J.; Grunder, F. I.; Moffitt, A. E.: Hydride generation atomic absorption Spectrophotometry for determination of arsenic in hair. Am Ind. Hyg. Assoc. Journal. 1978, 39, 933-938.
25. Agahian, B; Lee, J. S.; Nelson, J. H.: Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am Ind. Hyg. Assoc. J., 1990, 51(12), 646-651.